C-BRIDGE CAPITAL
C-Bridge Capital Partners identifies and unlocks opportunities to drive growth and development across borders. They leverage their expertise in the United States, China and Israel to help their global clients form international strategic alliances that achieve maximum returns. Using their unparalleled network and extensive knowledge, They facilitate cross-border investments and asset formation in the US, China and Israel. They remain involved to monitor and protect their clients’ investment interests.
C-BRIDGE CAPITAL
Social Links:
Founded:
2014-01-01
Status:
Active
Contact:
212 705 5001
Email Addresses:
[email protected]
Technology used in webpage:
Nginx Shockwave Flash Embed Baidu Analytics Dingfeng Xinhui
Similar Organizations
BioVenture
BioVenture is a Chinese venture capital firm that offers early and growth stage investment services.
Frazier Healthcare Partners
Frazier Healthcare Partners is a healthcare investment firm for pharmaceuticals, healthcare services, & medical products.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Syno Capital
Syno Capital is a principal investment firm focused on life science and healthcare sector investments in New York.
Third Point Ventures
Third Point Ventures is an investment firm that focuses on enterprise, fintech, mobile, and healthcare innovation.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-26 | RVAC Medicines | C-Bridge Capital investment in Series B - RVAC Medicines | 140 M USD |
| 2021-05-26 | NiKang Therapeutics | C-Bridge Capital investment in Series C - NiKang Therapeutics | 200 M USD |
| 2021-04-28 | Adcentrx Therapeutics | C-Bridge Capital investment in Series A - Adcentrx Therapeutics | 50 M USD |
| 2020-12-07 | Nuance Biotech | C-Bridge Capital investment in Series D - Nuance Biotech | 181 M USD |
| 2019-08-20 | GrayBug | C-Bridge Capital investment in Series C - GrayBug | 80 M USD |
| 2018-06-29 | I-Mab Biopharma | C-Bridge Capital investment in Series C - I-Mab Biopharma | 220 M USD |
| 2018-06-28 | Nuance Biotech | C-Bridge Capital investment in Series B - Nuance Biotech | 20 M USD |
| 2018-04-23 | CMLabs | C-Bridge Capital investment in Series C - CMLabs | 15.9 M USD |
| 2018-04-02 | CMAB BioPharm | C-Bridge Capital investment in Series B - CMAB BioPharm | 34 M USD |
| 2018-01-02 | CMAB BioPharm | C-Bridge Capital investment in Series A - CMAB BioPharm | 38 M USD |